Under the supervision of Prof. Arnér, being a world-authority in the field of selenoprotein research, SeLENOZYME is a unique world-wide provider of recombinant selenoproteins for customers in academic research, pharmaceutical industry and other fields of biotechnology. Their recombinant production system uses bacteria, making the production cost lower compared to use of mammalian systems, and allows them to offer selenoproteins at competitive prices compared to selenoproteins purified from native sources. This edge-cutting technology results from 30+ years of extensive research at Karolinska Institutet in Stockholm, Sweden, now making selenoproteins available for academic research and the global Pharma and R&D sectors. With their technology they could theoretically produce any of the 800+ natural selenoproteins yet identified in nature, or any synthetic selenocysteine-containing proteins on demand.
SeLENOZYME keeps a range of recombinant selenoproteins in stock for fast delivery and provides a tailored production service.